# US 2023/0400457 A1 · Modified elisa with hemoglobin correction apparatus and methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0400457 A1
- Document ID: US20230400457A1
- Status: Published application
- Kind: A1
- Application number: 18/034,448
- Filed: 2020-11-23
- Published: 2023-12-14
- Earliest claimed: 2020-11-23
- Assignees: Nova Biomedical Corporation
- Applicants: Nova Biomedical Corporation
- Inventors: Martina MEDKOVA; Daniel KING; Jeff CHIEN
- Web page: https://patentgrep.com/patent/US20230400457A1

## CPC

- G01N 33/5304: {Reaction vessels, e.g. agglutination plates (for solid-phase systems G01N33/543)}
- B01L 3/0275: {Interchangeable or disposable dispensing tips}
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/527: {for a plurality of reagents}
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- G01N 33/54386: {Analytical elements}
- B01L 2200/025: Align devices or objects to ensure defined positions relative to each other
- B01L 2200/04: Exchange or ejection of cartridges, containers or reservoirs
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/027: Digital display, e.g. LCD, LED
- B01L 2300/046: Function or devices integrated in the closure
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

A disposable bioassay diagnostic cartridge for performing enzyme-linked immunosorbent assay for a single patient in whole blood and plasma where the cartridge has a plurality of wells. The cartridge includes a pipette tip with internal sidewalls disposed in one well of the plurality of wells, the internal sidewalls being pretreated and coated with antibodies, a reagent mixture disposed in another well of the plurality of wells, the reagent mixture comprising at least one reagent selected from the group consisting of pH stabilizer, ionic catalyst control agent, ionic intracellular inhibitory control agent, detergent, negative control agent, chelating agent, and biocide preservative, antibody, and conjugate stabilizing agent. At least a chromogenic substrate and visualizing reagent disposed in an integrated cuvette of the plurality of wells. It also includes the detection of the hemoglobin amount in the blood sample so a correction for plasma amount in a sample can be performed.

## Claims

### Claim 1

A disposable bioassay diagnostic cartridge for performing enzyme-linked immunosorbent assay for a single patient wherein the cartridge has a plurality of wells, the cartridge comprising:
a pipette tip with internal sidewalls disposed in one well of the plurality of wells, the internal sidewalls being pretreated and coated with antibodies;
a reagent mixture disposed in another well of the plurality of wells, the reagent mixture comprising at least one reagent selected from the group consisting of pH stabilizer, ionic catalyst control agent, ionic intracellular inhibitory control agent, detergent, negative control agent, chelating agent, and biocide preservative, antibody, and conjugate stabilizing agent; and
at least a chromogenic substrate and visualizing reagent disposed in an integrated cuvette of the plurality of wells.

### Claim 2 (depends on 1)

The disposable cartridge according to claim 1, wherein the antibodies coating the internal sidewalls are selected from the group consisting of anti-c-reactive protein antibodies, anti-cystatin-c antibodies, anti-IGF-1 antibodies, anti-alanine aminotransferase antibodies, and anti-aspartate aminotransferase antibodies.

### Claim 3 (depends on 1)

The disposable cartridge according to claim 1, wherein the chromogenic substrate and the antibodies are present in a ratio of approximately 1:1.

### Claim 4 (depends on 1)

The disposable cartridge according to claim 1, wherein the chromogenic substrate is 3,3′,5,5′-tetramethylbenzidine.

### Claim 5 (depends on 1)

The disposable cartridge according to claim 1, wherein the at least one reagent is present in an amount corresponding to an amount of the chromogenic substrate and visualizing reagent.

### Claim 6 (depends on 1)

The disposable cartridge according to claim 1, wherein the at least one reagent consists of at least 150 uL of a reagent mixture of lysing solution with 0.002% saponin, 0.01% low-foaming surfactant, and 0.02% sodium azide.

### Claim 7 (depends on 1)

The disposable cartridge according to claim 1, wherein the third well having PBS, 0.05% polysorbate-type nonionic surfactant, and 0.03% biocide preservative.

### Claim 8 (depends on 1)

The disposable cartridge according to claim 1, further comprising a fourth well having antibodies selected from the group consisting of anti-c-reactive protein antibodies, anti-cystatin-c antibodies, anti-IGF-1 antibodies, anti-alanine aminotransferase antibodies, and anti-aspartate aminotransferase antibodies, conjugate stabilizing agent, and 0.5% antifoaming/defoaming agent.

### Claim 9 (depends on 1)

The disposable cartridge according to claim 1, wherein the antibodies coating the sidewalls of the pipette are anti-cystatin C antibodies; and the at least one reagent in the second well consists of lyse solution with 0.002% saponin, 0.01% low-foaming surfactant, and 0.02% sodium azide.

### Claim 10 (depends on 1)

The disposable cartridge according to claim 1, further comprising:
a fourth well having 10 mM PBS, 0.05% polysorbate-type nonionic surfactant, and 0.03% biocide preservative; and
a fifth well having antibodies selected from the group consisting of anti-c-reactive protein antibodies, anti-cystatin-c antibodies, anti-IGF-1 antibodies, anti-alanine aminotransferase antibodies, and anti-aspartate aminotransferase antibodies, conjugate stabilizing agent, and 0.5% an antifoaming/defoaming agent.

### Claim 11 (depends on 2)

The disposable cartridge according to claim 2, the integrated cuvette having first and second walls capable of facilitating a first optical detection reading via a first LED at 530 nm, and a second optical detection reading via a second LED at 660 nm.

### Claim 12

An enzyme-linked immunosorbent bioassay diagnostic kit comprising:
a fingerstick device; and
a cartridge having a plurality of wells and an optical cuvette, the cartridge having a pipette-tip disposed in one of the plurality of wells and bioassay components disposed in one or more remaining wells of the plurality of wells, and wherein one of the plurality of wells is an optical cuvette;
wherein the pipette tip has sidewalls coated with an antibody; and
wherein the bioassay components comprising at least one reagent being chosen from a group consisting of pH stabilizer, ionic catalyst control agent, ionic intracellular inhibitory control agent, detergent, negative control agent, chelating agent, and biocide preservative, an antibody, conjugate stabilizing agent, a chromogenic substrate, and visualizing reagent.

### Claim 13

A method of preparing a disposable pipette for use in performing enzyme-linked immunosorbent assays while reducing washing time, the method comprising steps of:
pretreating a pipette tip by coating an internal surface of the pipette tip, the pretreating step includes:
disposing a first coating containing an affinity agent along the internal surface of the pipette tip;
disposing a second coating containing a blocking solution over the first coating along the internal surface of the pipette tip;
disposing a third coating containing an activity preservative over the second coating along the internal surface of the pipette tip forming a coated pipette tip for use in performing enzyme-linked immunosorbent assays that reduces washing time by facilitating direct pipetting into the coated pipette tip with at least one reagent mixture being selected from the group consisting of pH stabilizer, ionic catalyst control agent, ionic intracellular inhibitory control agent, detergent, negative control agent, chelating agent, and biocide preservative, an antibody, and conjugate stabilizing agent; and
providing one well containing a chromogenic substrate and visualizing reagent within the cartridge for directly reacting the chromogenic substrate and visualizing reagent with the affinity agent in the coated pipette tip with.

### Claim 14 (depends on 13)

The method according to claim 13, further comprising: selecting the affinity agent from a group consisting of antibody, antibody fragment, recombinant protein, protein A, protein G, protein A/G, streptavidin, recombinant protein fragment, nucleic acid, polysaccharide, glycoprotein, peptidoglycans, molecular imprinted polymer, and aptamer molecule.

### Claim 15 (depends on 13)

The method according to claim 13, further comprising selecting a coating buffer from a group consisting of a carbonate/bicarbonate buffer, sucrose buffer, phosphate buffered saline, and tris(hydroxymethyl)aminomethane saline.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the step of disposing the first coating along the internal surface of the pipette tip with the affinity agent, the first coating step further comprising:
selecting the affinity agent;
selecting a coating buffer;
preparing an antibody solution by mixing the selected antibody and the selected coating buffer;
filling the pipette tips with the mixed antibody solution; and
incubating the pipette tips at a first temperature for a predefined time.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the step of disposing the second coating on top of the first coating along the internal surface of the pipette tip with the blocking solution, the second coating step further comprising:
selecting the blocking solution;
filling the pipette tips with the blocking solution; and
incubating the pipette tips at a second temperature for a predefined time.

### Claim 18 (depends on 13)

The method according to claim 13, wherein the step of disposing the third coating on top of the second coating along the internal surface of the pipette tip with the activity preservative, the third coating step further comprising:
selecting the activity preservative;
filling the pipette tips with the activity preservative; and
incubating the pipette tips at a third temperature for a predefined time.
